Respiratory Drugs Flashcards
Name 4 beta2-agonists?
- Salbutamol
- Salmeterol
- Formoterol
- Terbutaline
What are the indications for use of beta2-agonists?
- Asthma
- COPD
- Hyperkalaemia
In the treatment of asthma, when are short- and long- acting beta2-agonists used?
Short-acting beta2-agonists are used to relieve breathlessness.
Long-acting beta2-agonists are used as ‘step 3’ treatment for chronic asthma, but must always be given in combination with inhaled corticosteroids.
In the treatment of COPD, when are short- and long- acting beta2-agonists used?
Short-acting beta2-agonists are used to relieve breathlessness.
Long-acting beta2-agonists are an option for second-line therapy of COPD
In which form is salbutamol given as urgent treatment of a high serum potassium concentration (hyperkalaemia)? and which other drugs are given alongside it?
Nebulised salbutamol.
Given alongside insulin, glucose and calcium gluconate.
What is the mechanism of action of beta2-agonists in treating asthma/COPD?
Beta2-receptors are found in smooth muscle of the bronchi, GI tract, uterus and blood vessels. Stimulation of this G protein-coupled receptor activates a signalling cascade that leads to smooth muscle relaxation. This improves airflow in constricted airways, reducing the symptoms of breathlessness.
What is the mechanism of action of beta2-agonists in treating hyperkalaemia?
Like insulin, beta2-agonists stimulate Na+/K+-ATPase pumps on cell surface membranes, thereby causing a shift of K+ from the extracellular to intracellular compartment. This makes them a useful adjunct in the treatment of hyperkalaemia, particularly when IV access is difficult.
Why are other drugs needed to treat hyperkalaemia, as well as beta2-agonists?
The effect of beta2-agonists in treating hyperkalaemia is less reliable than other therapies, so they should not be used in isolation.
Which 2 beta2-agonists are short-acting and which are long-acting?
Short-acting: 1. Salbutamol 2. Terbutaline Long-acting: 1. Salmeterol 2. Formoterol
What are the possible side effects caused by beta2-agonists? (5)
Activation of beta2-receptors in other tissues accounts for the common ‘fight or flight’ adverse effects of:
1. Tachycardia
2. Palpitations
3. Anxiety
4. Tremor
They also promote glycogenolysis, so may increase the serum glucose concentration. At high doses, serum lactate levels may also rise. Long-acting beta2-agonists can cause muscle cramps.
What are the warnings associated with beta2-agonist use? (2)
- Long-acting beta2-agonists should be used in asthma only if an inhaled corticosteroid is also part of the therapy - this is because without a steroid, long-acting beta2-agonists are associated with increased asthma deaths.
- Care should be taken when prescribing them for patients with CVD, in whom tachycardia may provoke angina or arrhythmias.
What are the important interactions to note when prescribing beta2-agonists?
- Beta-blockers may reduce the effectiveness of beta2-agonists.
- Concomitant use of high-dose nebulised beta2-agonists with theophylline and corticosteroids can lead to hypokalaemia, so serum potassium concentrations should be monitored.
What is important to remember when prescribing nebuliser therapy?
You should always indicate whether the nebuliser should be driven by oxygen or air. In general, oxygen should be used in asthma, whereas medical air should be used in COPD, due to the risk of CO2 retention.
Name 3 anticholinergics/antimuscarinics/bronchodilators?
- Ipratropium
- Tiotropium
- Glycopyrronium
What are the 2 indications for use of antimuscarinics (anticholinergics)?
- COPD
2. Asthma
When are short- and long- acting antimuscarinics indicated for use in COPD?
Short-acting antimuscarinics are used to RELIEVE breathlessness brought on by exercise or during exacerbations.
Long-acting antimuscarinics (LAMAs) are used to PREVENT breathlessness and exacerbations
When are short- and long- acting antimuscarinics indicated for use in asthma?
Short-acting antimuscarinics are used in adjuvant treatment for relief of breathlessness during acute exacerbations (added to a short-acting beta2-agonist, e.g. salbutamol).
Long-acting antimuscarinics are added to high-dose inhaled corticosteroids and long-acting beta2-agonists at ‘step 4’ in the treatment of chronic asthma.
What is the mechanism of action of antimuscarinics?
Antimuscarinic drugs bind to the muscarinic receptor, where they act as a competitive inhibitor of acetylcholine. Stimulation of the muscarinic receptor brings about a wide range of parasympathetic ‘rest and digest’ effects. In blocking the receptor, antimuscarinics have the opposite effects: they increase heart rate and conduction; reduce smooth muscle tone, including in the respiratory tract; and reduce secretions from glands in the respiratory and GI tracts. In the eye they cause relaxation of the pupillary constrictor and ciliary muscles, causing pupillary dilatation and preventing accommodation, respectively.
What are the side effects caused by antimuscarinics? (1)
Other than a dry mouth, side effects are uncommon as when they are taken by inhalation, relatively little is absorbed systemically.
What are the warnings for use of antimuscarinics? (1)
Angle-closure glaucoma - they can precipitate a dangerous rise in intraocular pressure
Are there any important drug interactions to consider when prescribing antimuscarinics?
No - they are not generally a problem due to the low systemic absorption.
Name 3 systemic corticosteroids (glucocorticoids)?
- Prednisolone
- Hydrocortisone
- Dexamethasone
What are the common indications for use of systemic corticosteroids?
- To treat allergic or inflammatory disorders e.g. anaphylaxis, asthma.
- Suppression of autoimmune disease, e.g. IBD, inflammatory arthritis
- In the treatment of some cancers as part of chemotherapy or to reduce tumour-associated swelling
- Hormone replacement in adrenal insufficiency or hypopituitarism
What is the mechanism of action of systemic corticosteroids (glucocorticoids), and how they modify immune responses?
These glucocorticoids bind to cytosolic glucorticoid receptors, which then translocate to the nucleus and bind to glucorticoid-response elements, which regulate gene expression. Corticosteroids are most commonly prescribed to modify the immune response. They upregulate anti-inflammatory genes and downregular pro-inflammatory genes (e.g. cytokines, tumour necrosis factor alpha).
Direct actions on inflammatory cells include suppression of circulating monocytes and eosinophils.
What mineralocorticoid effects do systemic corticosteroids have?
They stimulate Na+ and water retention, and K+ excretion in the renal tubule.
What side effects are caused by systemic corticosteroid use? (6 ‘categories’)
- Immunosuppression increases the risk and severity of infection and alters the host response.
- Metabolic effects include diabetes mellitus and osteoporosis.
- Increased catabolism causes proximal muscle weakness, skin thinning with easy bruising and gastritis.
- Mood and behavioural changes include insomnia, confusion, psychosis and suicidal thoughts.
- Mineralocorticoid actions can result in hypertension, hypokalaemia and oedema.
- Corticosteroid treatment suppresses ACTH secretion, switching off the stimulus for normal adrenal cortisol production.